Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Market Insight - Infertility drugs: making miracle babies

This article was originally published in Scrip

Executive Summary

For most couples, starting a family is a joyful and exciting event, and 75% of women get pregnant within the first nine months of trying. However, for some women, the inability to become pregnant turns these emotions into fear and anger. According to the National Center for Health Statistics, there are 2.1 million infertile married couples in the US (10-15% of the population aged 12-50), and 9.2 million women are presently using infertility services. Globally, it is estimated that over 70 million couples are infertile.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC031635

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel